Stefan Bereswill - Infectious Diseases

Author Information

Stefan Bereswill is affiliated with the Institute of Microbiology, Infectious Diseases and Immunology, specifically within the Gastrointestinal Microbiology Research Group at Charité-University Medicine Berlin. This institution is a corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and the Berlin Institute of Health, located in Berlin, Germany.

Research Contributions

Stefan Bereswill has made significant contributions to the field of microbiology and infectious diseases. His research focuses extensively on the antibacterial effects of natural compounds, such as those found in hops and Artemisia, which hold promise for combating multi-drug resistant bacteria. He has also explored the therapeutic potential of garlic essential oil in treating acute campylobacteriosis and investigated the immune-modulatory properties of short-chain fatty acids, such as propionate. Additionally, his work extends to understanding the role of probiotics in alleviating inflammatory responses and the genetic regulation in Campylobacter jejuni infections.

Aliases

Stefan Bereswill is also known by the names S Bereswill and S. Bereswill in various publications.

Publication and Citation Metrics

Metric	Value
Citation Count	10,705
H-index	59
Paper Count	273

Publications:

Antibacterial effects of biologically active ingredients in hop provide promising options to fight infections by pathogens including multi-drug resistant bacteria.

DOI: 10.1556/1886.2022.00006

Year: 2022

Absinthe against multi-drug resistant bacterial pathogens? A recent update on the antibacterial effects of Artemisia compounds.

DOI: 10.1556/1886.2022.00007

Year: 2022

Garlic Essential Oil as Promising Option for the Treatment of Acute Campylobacteriosis—Results from a Preclinical Placebo-Controlled Intervention Study

DOI: 10.3390/microorganisms9061140

Year: 2021

A review of the antimicrobial and immune-modulatory properties of the gut microbiotaderived short chain fatty acid propionate – What is new?

DOI: 10.1556/1886.2021.00005

Year: 2021

Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism.

DOI: 10.1093/eurheartj/ehab644

Year: 2021

Treatment with the Probiotic Product Aviguard® Alleviates Inflammatory Responses during Campylobacter jejuni-Induced Acute Enterocolitis in Mice

DOI: 10.3390/ijms22136683

Year: 2021

Novel ADNP Syndrome Mice Reveal Dramatic Sex-Specific Peripheral Gene Expression With Brain Synaptic and Tau Pathologies

DOI: 10.1016/j.biopsych.2021.09.018

Year: 2021

Increased physical fitness levels of mountaineering athletes: a study of the effects of high-intensity interval training and oregon circuit training

DOI:

Year: 2021

The glycosyltransferase ST3GAL2 is regulated by miR-615-3p in the intestinal tract of Campylobacter jejuni infected mice

DOI: 10.1186/s13099-021-00437-1

Year: 2021

Galanin receptor 3 attenuates inflammation and influences the gut microbiota in an experimental murine colitis model

DOI: 10.1038/s41598-020-79456-y

Year: 2021

How is Neisseria gonorrhoeae transmitted?

What is the Treatment for Salmonella?

What Role Does the Immune System Play?

What are Host-Pathogen Interactions?

What are the Treatment Options?

What Are the Considerations for Treating Parasitic Infections?

How is Colonization Managed or Treated?

What are Current Eradication Efforts?

Why are Genomic Studies Important in Infectious Diseases?

What is Vaccine Hesitancy?

Partnered Content Networks

Relevant Topics